Literature DB >> 17477797

Programmed drug delivery: nanosystems for tumor targeting.

Ernst Wagner1.   

Abstract

Programmed nanoscaled systems are emerging that may be very useful for tumor-targeted drug delivery: novel nanoparticles are pre-programmed to alter their structure and properties during the drug delivery process to make them most effective for the different extra- and intracellular delivery steps. Programming is effected by the incorporation of molecular sensors that are able to respond to physical or biological stimuli, including changes in pH, redox potential or enzymes. Tumor-targeting principles include systemic passive targeting and active receptor targeting. Physical forces (e.g., electric or magnetic fields, ultrasound, hyperthermia or light) may contribute to focusing and triggered activation of nanosystems. Biological drugs delivered with programmed nanosystems also include plasmid DNA, small interfering RNA and related therapeutic nucleic acids formulated as 'synthetic viruses'.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17477797     DOI: 10.1517/14712598.7.5.587

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  14 in total

Review 1.  Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine.

Authors:  Eung-Sam Kim; Eun Hyun Ahn; Euiheon Chung; Deok-Ho Kim
Journal:  Mol Cells       Date:  2013-11-20       Impact factor: 5.034

2.  Biophysical characterization of copolymer-protected gene vectors.

Authors:  Daniel Hönig; Jason DeRouchey; Ralf Jungmann; Christian Koch; Christian Plank; Joachim O Rädler
Journal:  Biomacromolecules       Date:  2010-07-12       Impact factor: 6.988

3.  Promoting antitumor activities of hydroxycamptothecin by encapsulation into acid-labile nanoparticles using electrospraying.

Authors:  Xiaoming Luo; Guoqing Jia; Haixing Song; Chaoyu Liu; Guannan Wu; Xiaohong Li
Journal:  Pharm Res       Date:  2013-07-25       Impact factor: 4.200

Review 4.  Delivering nanomedicine to solid tumors.

Authors:  Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  Nat Rev Clin Oncol       Date:  2010-09-14       Impact factor: 66.675

Review 5.  Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection.

Authors:  Philipp M Klein; Ernst Wagner
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

Review 6.  Nanoparticle-based targeted drug delivery.

Authors:  Rajesh Singh; James W Lillard
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

Review 7.  3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers.

Authors:  Thomas Tyrel Goodman; Chee Ping Ng; Suzie Hwang Pun
Journal:  Bioconjug Chem       Date:  2008-09-13       Impact factor: 4.774

8.  An acid sensitive ketal-based polyethylene glycol-oligoethylenimine copolymer mediates improved transfection efficiency at reduced toxicity.

Authors:  Veronika Knorr; Manfred Ogris; Ernst Wagner
Journal:  Pharm Res       Date:  2008-08-27       Impact factor: 4.200

9.  Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.

Authors:  Xi He; Kaimin Cai; Yu Zhang; Yifei Lu; Qin Guo; Yujie Zhang; Lisha Liu; Chunhui Ruan; Qinjun Chen; Xinli Chen; Chao Li; Tao Sun; Jianjun Cheng; Chen Jiang
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-09       Impact factor: 9.229

Review 10.  Advances in the field of nanooncology.

Authors:  K K Jain
Journal:  BMC Med       Date:  2010-12-13       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.